Sectors
ETON
Eton Pharmaceuticals, Inc.
59.73
2 x 34.05
2 x 58.47
bid
ask
-
0.05
0.08%
03:08 PM
timesize
| Ytd | 253.22% | |
| 1y | 245.06% |
58.24
day range
59.78
14.35
52 week range
64.43
| Open | 59.04 | Prev Close | 59.78 | Low | 58.24 | High | 59.78 | Mkt Cap | 1.71B |
| Vol | 230.80K | Avg Vol | 536.43K | EPS | 0.39 | P/E | 153.13 | Forward P/E | 23.17 |
| Beta | 0.86 | Short Ratio | 2.25 | Inst. Own | 70.17% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 45.07 | 200-d Avg | 27.20 | 1yr Est | 71.00 |
| Income Statement | |||
| Total Revenue | 37.59M | ||
| Revenues (USD) | 37.59M | ||
| Cost of Revenue | 12.18M | ||
| Gross Profit | 25.41M | ||
| Operating Expenses | 12.62M | ||
| Research and Development Expense | 993.00K | ||
| Selling, General and Administrative Expense | 11.63M | ||
| Operating Income | 12.79M | ||
| Interest Expense | 1.08M | ||
| Income Tax Expense | 140.00K | ||
| Net Income | 11.58M | ||
| Net Income Common Stock | 11.58M | ||
| Net Income Common Stock (USD) | 11.58M | ||
| Consolidated Income | 11.58M | ||
| Earnings per Basic Share | 0.42 | ||
| Earnings per Basic Share (USD) | 0.42 | ||
| Earnings per Diluted Share | 0.35 | ||
| Earning Before Interest & Taxes (EBIT) | 12.79M | ||
| Earning Before Interest & Taxes (USD) | 12.79M | ||
| Weighted Average Shares | 27.64M | ||
| Weighted Average Shares Diluted | 32.79M | ||
| Balance Sheet | |||
| Cash and Equivalents | 26.85M | ||
| Cash and Equivalents (USD) | 26.85M | ||
| Trade and Non-Trade Receivables | 24.89M | ||
| Current Assets | 68.60M | ||
| Property, Plant & Equipment Net | 1.47M | ||
| Total Assets | 115.81M | ||
| Debt Current | 8.82M | ||
| Total Debt | 28.99M | ||
| Current Liabilities | 45.12M | ||
| Debt Non-Current | 20.16M | ||
| Total Liabilities | 69.22M | ||
| Accumulated Retained Earnings (Deficit) | -99.36M | ||
| Shareholders Equity | 46.59M | ||
| Shareholders Equity (USD) | 46.59M | ||
| Assets Non-Current | 47.21M | ||
| Total Debt (USD) | 28.99M | ||
| Goodwill and Intangible Assets | 45.68M | ||
| Inventory | 10.14M | ||
| Liabilities Non-Current | 24.10M | ||
| Trade and Non-Trade Payables | 14.41M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.42M | ||
| Net Cash Flow from Financing | -76.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 7.18M | ||
| Capital Expenditure | 5.00K | ||
| Issuance (Purchase) of Equity Shares | 2.92M | ||
| Issuance (Repayment) of Debt Securities | -3.00M | ||
| Net Cash Flow from Investing | 5.00K | ||
| Net Cash Flow from Operations | 7.26M | ||
| Share Based Compensation | 1.47M | ||